Nahdi Medical Co (SAU:4164) Piotroski F-Score: 5 (As of Jul. 02, 2026) — Near Median


SAU:4164 Nahdi Medical Co SAU:4164
61 GF Score
Price ﷼93.70
GF Value ﷼140.44
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Nahdi Medical Co Piotroski F-Score?

Nahdi Medical Co SAU:4164 +0.75% 61 Piotroski F-Score is 5 as of Jul. 02, 2026, which is at its 10-year median of 5.00. GuruFocus rates SAU:4164 with a GF Score™ of 61/100 and a GF Value™ of ﷼140.44 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 651 Healthcare Providers & Services companies, Nahdi Medical Co ranks better than 54.38% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Nahdi Medical Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Nahdi Medical Co's Piotroski F-Score or its related term are showing as below:

SAU:4164' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 5   Max: 6
Current: 5

During the past 5 years, the highest Piotroski F-Score of Nahdi Medical Co was 6. The lowest was 4. And the median was 5.

Nahdi Medical Co  (SAU:4164) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Nahdi Medical Co Piotroski F-Score Related Terms


Nahdi Medical Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Nahdi Medical Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nahdi Medical Co Piotroski F-Score Chart

Nahdi Medical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
N/A N/A 4.00 4.00 4.00

Nahdi Medical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 4.00 4.00 4.00 5.00

Nahdi Medical Co Piotroski F-Score Competitor Comparison

For the Pharmaceutical Retailers subindustry, Nahdi Medical Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nahdi Medical Co Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nahdi Medical Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Nahdi Medical Co's Piotroski F-Score falls into.


SAU:4164
61GF Score
Nahdi Medical Co SAU:4164
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 238.403 + 161.249 + 175.922 + 235.683 = ﷼811 Mil.
Cash Flow from Operations was -124.153 + 498.735 + 127.398 + 857.752 = ﷼1,360 Mil.
Revenue was 2527.565 + 2461.457 + 2589.263 + 2794.442 = ﷼10,373 Mil.
Gross Profit was 965.953 + 940.569 + 955.225 + 987.732 = ﷼3,849 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(6526.36 + 6383.488 + 6761.763 + 6690.882 + 7414.445) / 5 = ﷼6755.3876 Mil.
Total Assets at the begining of this year (Mar25) was ﷼6,526 Mil.
Long-Term Debt & Capital Lease Obligation was ﷼1,382 Mil.
Total Current Assets was ﷼4,037 Mil.
Total Current Liabilities was ﷼3,006 Mil.
Net Income was 247.736 + 182.188 + 157.85 + 255.164 = ﷼843 Mil.

Revenue was 2472.664 + 2353.252 + 2363.007 + 2634.953 = ﷼9,824 Mil.
Gross Profit was 938.681 + 845.362 + 875.365 + 943.824 = ﷼3,603 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(5675.553 + 5759.088 + 5914.058 + 6173.349 + 6526.36) / 5 = ﷼6009.6816 Mil.
Total Assets at the begining of last year (Mar24) was ﷼5,676 Mil.
Long-Term Debt & Capital Lease Obligation was ﷼1,216 Mil.
Total Current Assets was ﷼3,357 Mil.
Total Current Liabilities was ﷼2,416 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Nahdi Medical Co's current Net Income (TTM) was 811. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Nahdi Medical Co's current Cash Flow from Operations (TTM) was 1,360. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=811.257/6526.36
=0.12430467

ROA (Last Year)=Net Income/Total Assets (Mar24)
=842.938/5675.553
=0.14852086

Nahdi Medical Co's return on assets of this year was 0.12430467. Nahdi Medical Co's return on assets of last year was 0.14852086. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Nahdi Medical Co's current Net Income (TTM) was 811. Nahdi Medical Co's current Cash Flow from Operations (TTM) was 1,360. ==> 1,360 > 811 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=1381.624/6755.3876
=0.2045218

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=1216.176/6009.6816
=0.20236946

Nahdi Medical Co's gearing of this year was 0.2045218. Nahdi Medical Co's gearing of last year was 0.20236946. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=4036.518/3005.567
=1.34301381

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=3356.814/2415.653
=1.38960935

Nahdi Medical Co's current ratio of this year was 1.34301381. Nahdi Medical Co's current ratio of last year was 1.38960935. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Nahdi Medical Co's number of shares in issue this year was 130. Nahdi Medical Co's number of shares in issue last year was 130. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=3849.479/10372.727
=0.37111543

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=3603.232/9823.876
=0.36678313

Nahdi Medical Co's gross margin of this year was 0.37111543. Nahdi Medical Co's gross margin of last year was 0.36678313. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=10372.727/6526.36
=1.58935869

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=9823.876/5675.553
=1.7309108

Nahdi Medical Co's asset turnover of this year was 1.58935869. Nahdi Medical Co's asset turnover of last year was 1.7309108. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+0+0+1+1+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Nahdi Medical Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Nahdi Medical Co (SAU:4164) has a Piotroski F-Score of 5 as of Jul. 02, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Nahdi Medical Co and its competitors. This is near median its historical median of 5.00. Over the past decade, Nahdi Medical Co's Piotroski F-Score has ranged from 4.00 to 6.00. According to the industry distribution chart, Nahdi Medical Co ranks #297 out of 651 companies in the Healthcare Providers & Services industry, placing it in the top 45.6%.
Is Nahdi Medical Co's Piotroski F-Score too high?
Nahdi Medical Co's current Piotroski F-Score of 5 is near median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 6.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Nahdi Medical Co's value of 5 is 0% at this industry median. Based on the distribution chart, Nahdi Medical Co ranks #297 out of 651 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Nahdi Medical Co has a GF Score™ of 61/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nahdi Medical Co's Piotroski F-Score compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Nahdi Medical Co ranks #297 out of 651 companies for Piotroski F-Score. This puts Nahdi Medical Co in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Nahdi Medical Co's value of 5 is 0% at this benchmark. Historically, Nahdi Medical Co's own Piotroski F-Score has ranged from 4.00 to 6.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Nahdi Medical Co has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 651 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nahdi Medical Co's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Nahdi Medical Co and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nahdi Medical Co's current Piotroski F-Score is 5, which is near median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nahdi Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Nahdi Medical Co (SAU:4164) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼140.44, compared to a current price of ﷼93.70 — trading 33.3% below its estimated fair value. The current Piotroski F-Score is 5, which is near median its 10-year median of 5.00 and 0% at the Healthcare Providers & Services industry median of 5.00. Nahdi Medical Co's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Nahdi Medical Co (SAU:4164), the current Piotroski F-Score is 5 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nahdi Medical Co (SAU:4164) Overvalued in 2026?

Based on GuruFocus' analysis, Nahdi Medical Co stock appears to be undervalued. The current stock price of ﷼93.70 is trading 33.3% below its estimated GF Value™ of ﷼140.44. GuruFocus considers Nahdi Medical Co to be Significantly Undervalued.

Key valuation signals for SAU:4164:

  • Piotroski F-Score: 5 (near median its 10-year median of 5.00)
  • GF Value™: ﷼140.44 vs. price of ﷼93.70 (33.3% below fair value)
  • GF Score™: 61/100 with 2 warning signs
  • Industry Position: 0% at the Healthcare Providers & Services median (#297 of 651)

No single metric tells the full story. See the SAU:4164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nahdi Medical Co Business Description

Address Ibrg Alraghama, PO Box 17129, Jeddah, SAU, 21484
Nahdi Medical Co is engaged in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods, and medical equipment. It has two operating segments: Front Shop and Pharma.
61GF Score

Get the complete analysis for SAU:4164

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼93.70
Price
﷼140.44
GF Value